Advances in drug delivery: improved bioavailability and drug effect

Area of Science:

• Pharmacology
• Drug Delivery Systems
• Medicinal Chemistry

Background:

• Anticholinergic agents' efficacy and tolerability are closely linked to their bioavailability.
• Drug metabolism, particularly intestinal metabolism, significantly affects anticholinergic drug levels.
• Optimizing drug delivery can enhance patient compliance and overall therapeutic effect.

Purpose of the Study:

• To explore how drug delivery alterations impact anticholinergic agent bioavailability.
• To establish the relationship between metabolism, drug delivery, and therapeutic outcomes.
• To identify improved drug delivery strategies for anticholinergic agents.

Main Methods:

• Review of existing literature on anticholinergic drug metabolism and delivery routes.
• Analysis of how specific delivery methods affect bioavailability of agents like oxybutynin chloride and tolterodine tartrate.
• Evaluation of extended-release, cutaneous, intravesical, and intravaginal delivery systems.

Main Results:

• Delivery techniques that bypass or reduce intestinal metabolism, such as extended-release oral and alternative routes, improve oxybutynin chloride bioavailability.
• Long-acting formulations of tolterodine tartrate enhance efficacy and reduce side effects like dry mouth (xerostomia).
• Stable serum-drug concentrations achieved through advanced delivery systems contribute to positive therapeutic effects.

Conclusions:

• Drug delivery modifications are crucial for optimizing anticholinergic agent bioavailability, efficacy, and tolerability.
• Targeting intestinal metabolism through innovative delivery routes offers a promising strategy for enhancing drug performance.
• Improved drug delivery systems lead to better patient compliance and treatment outcomes for anticholinergic therapies.